ArticleInternational journal of hematology2026
Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.
Keita Ishii et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it